Kinetic measures of a cerebrospinal fluid (CSF) biomarker test predicted cognitive decline in Parkinson's disease and ...

Progressive supranuclear palsy is a rare condition that affects the brain. The condition is also called Steele-Richardson-Olszewski syndrome. Progressive supranuclear palsy causes the brain cells ...

A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of ...

Progressive supranuclear palsy (PSP) is an uncommon brain disorder. It affects many areas of function, including a person's ...

FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.

On Monday, however, the 55-year-old revealed that doctors had determined she actually suffers from the more serious progressive supranuclear palsy (PSP), which she called “a kind of ‘Parkinson ...

Dublin, July 03, 2020 (GLOBE NEWSWIRE) -- The "Progressive supranuclear palsy (PSP) - Market Insights, Epidemiology and Market Forecast-2030" drug pipelines has been added to ResearchAndMarkets ...

I took care of her at home from the day she was diagnosed till I held her in my arms when she took her last breath and it was ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the progressive supranuclear palsy market. The report includes a detailed analysis of the pipeline ...

The Key Progressive Supranuclear Palsy Companies in the market include - Woolsey Pharmaceutical, Asahi Kasei Pharma, AlzProtect, Amylyx Pharmaceuticals, Transposon Therapeutics, Oncolys Biopharma ...